10 research outputs found
TB treatment initiation, overall and by HIV status, in the Xpert and routine arms for both the ITT and per protocol analyses.
<p>TB treatment initiation, overall and by HIV status, in the Xpert and routine arms for both the ITT and per protocol analyses.</p
Proportion of HIV-infected and -uninfected participants initiating TB treatment by time to treatment initiation for both study arms, ITT analysis.
<p>Xpert: solid line; routine: dashed line. (A) HIV-infected individuals (<i>p</i><0.001); (B) HIV-uninfected individuals (<i>p</i> = 0.778).</p
Proportion of participants initiating TB treatment by time to TB treatment initiation for both study arms, ITT analysis (<i>p</i> = 0.0042).
<p>Xpert: solid line; routine: dashed line.</p
Microbiological results by study arm for both the ITT and per protocol analyses.
<p>Microbiological results by study arm for both the ITT and per protocol analyses.</p
Number and percentage of participants for whom culture was requested by indication across study arms (ITT analysis).
<p>Number and percentage of participants for whom culture was requested by indication across study arms (ITT analysis).</p
Diagnostic testing algorithm for each study arm.
<p>Diagnostic testing algorithm for each study arm.</p
Clinical and demographic characteristics of participants by study arm for both the ITT and per protocol analyses.
<p>Clinical and demographic characteristics of participants by study arm for both the ITT and per protocol analyses.</p
Participants initiating TB treatment with confirmed TB (bacteriologically positive) and unconfirmed TB, overall and by HIV status (ITT analysis).
<p>Participants initiating TB treatment with confirmed TB (bacteriologically positive) and unconfirmed TB, overall and by HIV status (ITT analysis).</p
Treatment outcomes for all participants and HIV-infected participants (excluding rifampicin-resistant TB) by study arm (ITT analysis).
<p>Treatment outcomes for all participants and HIV-infected participants (excluding rifampicin-resistant TB) by study arm (ITT analysis).</p